STVN Stevanato Group S.p.A. logo

STVN Stevanato Group S.p.A.

Healthcare
$18.01+0.90%ClosedMarket Cap: $4.92B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

26.71

PEG

1.45

P/B

2.76

P/S

3.52

EV/EBITDA

15.70

DCF Value

$-7.89

FCF Yield

-0.2%

Div Yield

0.3%

Margins & Returns

Gross Margin

29.0%

Operating Margin

16.6%

Net Margin

11.7%

ROE

9.6%

ROA

5.5%

ROIC

6.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$273.6M$28.0M$
Q4 null$343.3M$47.2M$
FY null$1.14B$134.3M$
Q3 null$303.2M$36.1M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$24.50

Target (Median)

$24.00

Target Range

$17.50 - $32.00

2 Strong Buy6 Buy2 Hold0 Sell0 Strong Sell
Morgan StanleyEqual Weight
2026-03-06
CitigroupBuy
2026-03-05
KeybancOverweight
2026-03-05
Morgan StanleyEqual Weight
2025-12-02

Trading Activity

Insider Trades

View All
Santel Lucianodirector
SellWed Mar 25
Magistretti Elisabetta
SellWed Mar 25
Stevanato Sergio
SellWed Mar 18
Stevanato Franco
SellWed Mar 18
Spinazzi Alvisedirector
SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

IT

Exchange

Beta

0.76

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Peers